首页 > 最新文献

Molecular Imaging and Radionuclide Therapy最新文献

英文 中文
Comparison of Radioactive Iodine Activities in Terms of Short- and Long-term Results in Ablation Therapy in Patients with Low-risk Differentiated Thyroid Cancer. 低危分化型甲状腺癌消融治疗中放射性碘活性的短期和长期效果比较
IF 0.9 Q3 Medicine Pub Date : 2023-06-20 DOI: 10.4274/mirt.galenos.2022.05826
Seray Saraçoğlu, Osman Güven, Gündüzalp Buğrahan Babacan, Savaş Karyağar, Tamer Özülker, Sadık Ergür, Sevda Sağlampınar Karyağar
Objectives: The aim of this study was to compare the treatment responses after ablation with 30-50 mCi radioactive iodine (RAI) and 100 mCi RAI in patients with differentiated thyroid cancer (DTC) who were in the low-risk group according to 2015 American Thyroid Associations Classification (ATA 2015) criteria. Methods: Between February 2016 and August 2018, 100 patients who received RAI treatment in our clinic after total thyroidectomy and who were in the low-risk group DTC were included in this retrospective study. These patients were divided into 2 groups: low-activity (30-50 mCi) (group 1) and high-activity (100 mCi) (group 2). While 54 patients were treated with low activity, 46 patients received high activity RAI. The 2 groups were compared according to the 1st- and 3rd-year treatment response status. Results: According to the first-year follow-up, 15 patients were accepted as indeterminate response and 85 patients as excellent response. Three (5.5%) of the patients who were accepted as indeterminate response were in group 1 and 12 (26%) were in group 2. According to the third year follow-up, 1 patient in group 1 and 3 patients in group 2 were accepted as indeterminate response. No biochemical incomplete response or recurrent disease was detected. In the chi-square analysis performed to investigate the relationship between the first-year treatment response and RAI activities, a significant relationship was found (p=0.004). In the Mann-Whitney U test performed to investigate the parameters that may be effective in the treatment response, only the preablative serum thyroglobulin value was shown to have a significant difference between the two groups (p=0.01). In the long-term follow-up of the patients, based on the third year treatment response data, chi-square analysis was performed to evaluate the two groups in terms of treatment responses, and no statistically significant relationship was found (p=0.73). Conclusion: Ablation with 30-50 mCi can be safely applied in DTC patients who are in the ATA 2015 low-risk group and are planned for RAI ablation treatment.
目的:比较2015年美国甲状腺协会分类(ATA 2015)低危组分化型甲状腺癌(DTC)患者应用30-50 mCi放射性碘(RAI)和100 mCi放射性碘(RAI)消融后的治疗反应。方法:选取2016年2月至2018年8月在我院接受甲状腺全切除术后RAI治疗的低危组DTC患者100例进行回顾性研究。这些患者被分为2组:低活性(30-50 mCi)(1组)和高活性(100 mCi)(2组)。54例患者接受低活性治疗,46例患者接受高活性RAI治疗。比较两组患者1年、3年治疗反应情况。结果:经1年随访,15例为不确定缓解,85例为优缓解。1组有3例(5.5%)被认为反应不确定,2组有12例(26%)。经3年随访,1组1例,2组3例为反应不确定。未发现生化反应不完全或疾病复发。在卡方分析中,研究第一年治疗反应与RAI活性之间的关系,发现显著相关(p=0.004)。在研究可能对治疗反应有效的参数的Mann-Whitney U检验中,两组之间只有消融前血清甲状腺球蛋白值有显著差异(p=0.01)。在对患者的长期随访中,以第3年治疗反应数据为基础,采用卡方分析对两组治疗反应进行评价,无统计学意义(p=0.73)。结论:在ATA 2015低危组中计划进行RAI消融治疗的DTC患者中,30-50 mCi消融可以安全应用。
{"title":"Comparison of Radioactive Iodine Activities in Terms of Short- and Long-term Results in Ablation Therapy in Patients with Low-risk Differentiated Thyroid Cancer.","authors":"Seray Saraçoğlu, Osman Güven, Gündüzalp Buğrahan Babacan, Savaş Karyağar, Tamer Özülker, Sadık Ergür, Sevda Sağlampınar Karyağar","doi":"10.4274/mirt.galenos.2022.05826","DOIUrl":"https://doi.org/10.4274/mirt.galenos.2022.05826","url":null,"abstract":"Objectives: The aim of this study was to compare the treatment responses after ablation with 30-50 mCi radioactive iodine (RAI) and 100 mCi RAI in patients with differentiated thyroid cancer (DTC) who were in the low-risk group according to 2015 American Thyroid Associations Classification (ATA 2015) criteria. Methods: Between February 2016 and August 2018, 100 patients who received RAI treatment in our clinic after total thyroidectomy and who were in the low-risk group DTC were included in this retrospective study. These patients were divided into 2 groups: low-activity (30-50 mCi) (group 1) and high-activity (100 mCi) (group 2). While 54 patients were treated with low activity, 46 patients received high activity RAI. The 2 groups were compared according to the 1st- and 3rd-year treatment response status. Results: According to the first-year follow-up, 15 patients were accepted as indeterminate response and 85 patients as excellent response. Three (5.5%) of the patients who were accepted as indeterminate response were in group 1 and 12 (26%) were in group 2. According to the third year follow-up, 1 patient in group 1 and 3 patients in group 2 were accepted as indeterminate response. No biochemical incomplete response or recurrent disease was detected. In the chi-square analysis performed to investigate the relationship between the first-year treatment response and RAI activities, a significant relationship was found (p=0.004). In the Mann-Whitney U test performed to investigate the parameters that may be effective in the treatment response, only the preablative serum thyroglobulin value was shown to have a significant difference between the two groups (p=0.01). In the long-term follow-up of the patients, based on the third year treatment response data, chi-square analysis was performed to evaluate the two groups in terms of treatment responses, and no statistically significant relationship was found (p=0.73). Conclusion: Ablation with 30-50 mCi can be safely applied in DTC patients who are in the ATA 2015 low-risk group and are planned for RAI ablation treatment.","PeriodicalId":44681,"journal":{"name":"Molecular Imaging and Radionuclide Therapy","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2023-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/01/47/MIRT-32-112.PMC10284181.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9712046","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
The Evaluation of Sentinel Lymph Node Biopsy Using Radiocolloid in First Stage Endometrial Cancer. 对子宫内膜癌一期患者使用放射性胶体进行前哨淋巴结活检的评估
IF 0.9 Q4 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2023-06-20 DOI: 10.4274/mirt.galenos.2022.36097
Anamarija Jankulovska, Sinisha Stojanoski, Sasho Stojcevski, Igor Aluloski, Rubens Jovanovic, Slavica Kostadinova Kunovska, Mile Tanturovski, Nevena Manevska, Gordana Petrusevska, Daniela Miladinova

Objectives: Detection of a sentinel lymph node (SLN) in patients with endometrial cancer (EC) reduces the rate of unnecessary systemic lymph dissection. The aim of this study was to assess the SLN detection rate, accuracy of the method using Tc-99m-SENTI-SCINT and the rate of metastatic nodal involvement in patients with preoperative first stage EC.

Methods: A prospective study of SLN biopsy of 41 patients with stage I EC was conducted after cervical application of 4mCi Tc-99m-SENTI-SCINT. Planar lymphoscintigraphy and single-photon emission computed tomography/computed tomography (SPECT/CT) of the pelvis were performed, followed by site-specific lymphadenectomy in intermediate-risk patients if no SLN was detected per hemipelvis and pelvic lymphadenectomy in all high-risk patients.

Results: Pre-operative detection rate of planar lymphoscintigraphy was 80.49 [95% confidence interval (CI): 68.36-92.62] and of SPECT/CT 95.12 (95% CI: 88.52-101.7). The total intraoperative SLN detection rate was 95.12 (95% CI: 88.52-101.7) per patient and 26.83 (95% CI: 19.91-33.75) bilaterally. The average number of SLNs removed was 1.6±0.8. The most common anatomical location of SLN was the right external iliac region. The SLN metastatic rate was 17%. Both sensitivity and negative predictive value regarding metastatic involvement were 100%.

Conclusion: The SLN detection rate, sensitivity and negative predictive value using Tc-99m-SENTI-SCINT in patients with EC in our study were high. The application of ultra-staging in the histopathological analysis of SLN increases the detection of nodal metastases and improves the staging in these patients.

目的:检测子宫内膜癌(EC)患者的前哨淋巴结(SLN)可降低不必要的全身淋巴清扫率。本研究旨在评估前哨淋巴结的检出率、使用 Tc-99m-SENTI-SCINT 方法的准确性以及术前一期 EC 患者的转移性结节受累率:方法:在宫颈应用4mCi Tc-99m-SENTI-SCINT后,对41例I期EC患者进行SLN活检的前瞻性研究。对中危患者进行平面淋巴管造影和盆腔单光子发射计算机断层扫描/计算机断层扫描(SPECT/CT),如果半骨盆未检测到SLN,则对中危患者进行特定部位淋巴结切除术,对所有高危患者进行盆腔淋巴结切除术:术前平面淋巴管造影的检出率为 80.49 [95% 置信区间 (CI):68.36-92.62],SPECT/CT 的检出率为 95.12 (95% CI:88.52-101.7)。每位患者术中SLN总检出率为95.12(95% CI:88.52-101.7),双侧为26.83(95% CI:19.91-33.75)。切除的 SLN 平均数量为 1.6±0.8。SLN最常见的解剖位置是右侧髂外区域。SLN转移率为17%。结论:SLN检测率、敏感性和阴性预测值均为100%:结论:在我们的研究中,使用锝-99m-SENTI-SCINT对EC患者进行SLN检测的检出率、灵敏度和阴性预测值都很高。在 SLN 组织病理学分析中应用超分期技术可提高对结节转移的检出率,改善对这些患者的分期。
{"title":"The Evaluation of Sentinel Lymph Node Biopsy Using Radiocolloid in First Stage Endometrial Cancer.","authors":"Anamarija Jankulovska, Sinisha Stojanoski, Sasho Stojcevski, Igor Aluloski, Rubens Jovanovic, Slavica Kostadinova Kunovska, Mile Tanturovski, Nevena Manevska, Gordana Petrusevska, Daniela Miladinova","doi":"10.4274/mirt.galenos.2022.36097","DOIUrl":"10.4274/mirt.galenos.2022.36097","url":null,"abstract":"<p><strong>Objectives: </strong>Detection of a sentinel lymph node (SLN) in patients with endometrial cancer (EC) reduces the rate of unnecessary systemic lymph dissection. The aim of this study was to assess the SLN detection rate, accuracy of the method using Tc-99m-SENTI-SCINT and the rate of metastatic nodal involvement in patients with preoperative first stage EC.</p><p><strong>Methods: </strong>A prospective study of SLN biopsy of 41 patients with stage I EC was conducted after cervical application of 4mCi Tc-99m-SENTI-SCINT. Planar lymphoscintigraphy and single-photon emission computed tomography/computed tomography (SPECT/CT) of the pelvis were performed, followed by site-specific lymphadenectomy in intermediate-risk patients if no SLN was detected per hemipelvis and pelvic lymphadenectomy in all high-risk patients.</p><p><strong>Results: </strong>Pre-operative detection rate of planar lymphoscintigraphy was 80.49 [95% confidence interval (CI): 68.36-92.62] and of SPECT/CT 95.12 (95% CI: 88.52-101.7). The total intraoperative SLN detection rate was 95.12 (95% CI: 88.52-101.7) per patient and 26.83 (95% CI: 19.91-33.75) bilaterally. The average number of SLNs removed was 1.6±0.8. The most common anatomical location of SLN was the right external iliac region. The SLN metastatic rate was 17%. Both sensitivity and negative predictive value regarding metastatic involvement were 100%.</p><p><strong>Conclusion: </strong>The SLN detection rate, sensitivity and negative predictive value using Tc-99m-SENTI-SCINT in patients with EC in our study were high. The application of ultra-staging in the histopathological analysis of SLN increases the detection of nodal metastases and improves the staging in these patients.</p>","PeriodicalId":44681,"journal":{"name":"Molecular Imaging and Radionuclide Therapy","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2023-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/56/e5/MIRT-32-103.PMC10284191.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9709417","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
18F-FDG PET/MRI Image of Skin Metastasis of Ovarian Cancer. 卵巢癌皮肤转移的 18F-FDG PET/MRI 图像。
IF 0.9 Q4 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING Pub Date : 2023-06-20 DOI: 10.4274/mirt.galenos.2022.97268
Ali Kibar, Sertaç Asa, Rabia Lebriz Uslu Beşli, Muhammet Sait Sağer, Kerim Sönmezoğlu

Ovarian cancer is one of the deadliest tumors among women. It mostly metastasizes to the liver, pleura, lungs, and bones. We present a sixty-six-year-old patient with skin lesions. The patient who underwent biopsy due to skin lesions was diagnosed with ovarian cancer. 18F-fluorodeoxyglucose (FDG) positron emission tomography/magnetic resonance imaging (PET/MRI) performed for metastasis search shows widespread skin involvement, especially in the lower abdomen and legs. Skin involvement it ovarian cancer can be rarely seen, and in this article we would like to share 18F-FDG PET/MRI of skin involvement in ovarian cancer.

卵巢癌是女性中最致命的肿瘤之一。它主要转移到肝脏、胸膜、肺和骨骼。我们为您介绍一位六十六岁的皮损患者。患者因皮肤病变接受了活组织检查,确诊为卵巢癌。为寻找转移灶而进行的 18F-氟脱氧葡萄糖(FDG)正电子发射断层扫描/磁共振成像(PET/MRI)显示皮肤广泛受累,尤其是在下腹部和腿部。卵巢癌的皮肤受累很少见,本文将分享卵巢癌皮肤受累的18F-FDG PET/MRI。
{"title":"<sup>18</sup>F-FDG PET/MRI Image of Skin Metastasis of Ovarian Cancer.","authors":"Ali Kibar, Sertaç Asa, Rabia Lebriz Uslu Beşli, Muhammet Sait Sağer, Kerim Sönmezoğlu","doi":"10.4274/mirt.galenos.2022.97268","DOIUrl":"10.4274/mirt.galenos.2022.97268","url":null,"abstract":"<p><p>Ovarian cancer is one of the deadliest tumors among women. It mostly metastasizes to the liver, pleura, lungs, and bones. We present a sixty-six-year-old patient with skin lesions. The patient who underwent biopsy due to skin lesions was diagnosed with ovarian cancer. <sup>18</sup>F-fluorodeoxyglucose (FDG) positron emission tomography/magnetic resonance imaging (PET/MRI) performed for metastasis search shows widespread skin involvement, especially in the lower abdomen and legs. Skin involvement it ovarian cancer can be rarely seen, and in this article we would like to share <sup>18</sup>F-FDG PET/MRI of skin involvement in ovarian cancer.</p>","PeriodicalId":44681,"journal":{"name":"Molecular Imaging and Radionuclide Therapy","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2023-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/03/15/MIRT-32-159.PMC10284179.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9706697","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Incidental Spleen Cyst Mimicking Thyroid Carcinoma Metastasis: False-positive Uptake on Radioiodine Whole Body Scan. 偶发性脾囊肿模拟甲状腺癌转移:放射性碘全身扫描假阳性摄取。
IF 0.9 Q3 Medicine Pub Date : 2023-06-20 DOI: 10.4274/mirt.galenos.2023.24992
Mustafa Genç, Nazım Coşkun, Seyda Türkölmez

In differentiated thyroid cancer, radioiodine therapy and whole body scans (WBS) are integral part of disease management. We present the case of a 33-year-old woman with multifocal thyroid carcinoma who was treated with radioiodine. Post-treatment WBS scintigraphy showed focal increased I-131 uptake in the spleen, although stimulated thyroglobulin level was not suggestive of distant metastasis. Dynamic magnetic resonance imaging performed later revealed that the finding was an incidental splenic cyst. Radioiodine uptake is not specific to the thyroid tissue. Benign pathologies showing increased radioiodine uptake should be considered in cases with splenic radioiodine accumulation in WBSs.

在分化型甲状腺癌中,放射性碘治疗和全身扫描(WBS)是疾病管理的组成部分。我们提出的情况下,一个33岁的妇女多灶性甲状腺癌谁是放射性碘治疗。治疗后WBS显像显示脾脏局灶性I-131摄取增加,但刺激的甲状腺球蛋白水平并未提示远处转移。随后进行的动态磁共振成像显示该发现是一个偶然的脾囊肿。放射性碘的摄取并不局限于甲状腺组织。良性病理显示增加放射性碘摄取应考虑在脾放射性碘积累的情况下,WBSs。
{"title":"Incidental Spleen Cyst Mimicking Thyroid Carcinoma Metastasis: False-positive Uptake on Radioiodine Whole Body Scan.","authors":"Mustafa Genç,&nbsp;Nazım Coşkun,&nbsp;Seyda Türkölmez","doi":"10.4274/mirt.galenos.2023.24992","DOIUrl":"https://doi.org/10.4274/mirt.galenos.2023.24992","url":null,"abstract":"<p><p>In differentiated thyroid cancer, radioiodine therapy and whole body scans (WBS) are integral part of disease management. We present the case of a 33-year-old woman with multifocal thyroid carcinoma who was treated with radioiodine. Post-treatment WBS scintigraphy showed focal increased I-131 uptake in the spleen, although stimulated thyroglobulin level was not suggestive of distant metastasis. Dynamic magnetic resonance imaging performed later revealed that the finding was an incidental splenic cyst. Radioiodine uptake is not specific to the thyroid tissue. Benign pathologies showing increased radioiodine uptake should be considered in cases with splenic radioiodine accumulation in WBSs.</p>","PeriodicalId":44681,"journal":{"name":"Molecular Imaging and Radionuclide Therapy","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2023-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/7d/d1/MIRT-32-175.PMC10284186.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9706694","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Meningioma Mimicking Bone Metastasis in Breast Cancer. 模拟乳腺癌骨转移的脑膜瘤。
IF 0.9 Q3 Medicine Pub Date : 2023-06-20 DOI: 10.4274/mirt.galenos.2022.31032
Oğuzhan Şahin, Gündüzalp Buğrahan Babacan, Tamer Özülker

Meningiomas constitute 37% of primary central nervous system tumors and are more common in women. Also may occur with other primary malignancies, which can cause confusion with the metastasis in whole body bone scan (WBBS) imaging. A 58-year-old woman diagnosed with breast cancer was referred to the WBBS for the investigation of possible bone metastases. In the planar images, radiotracer uptake at multiple sites was detected on the anterior side of the skull base and the posterior side of the vertex of the cranium. Single photon emission computed tomography/computed tomography was performed for anatomical localization of possible metastatic lesions, and it revealed that detected accumulations of radiotracer did not belong to the bone metastases; uptakes were located at the cerebral parenchyma and the lesions in the falx cerebri. Patient history explained that she had been diagnosed with meningioma five years ago, which mimicked bone metastases in this study.

脑膜瘤占原发性中枢神经系统肿瘤的37%,在女性中更为常见。也可能发生在其他原发性恶性肿瘤中,这在全身骨扫描(WBBS)成像中可能与转移混淆。一名58岁的女性被诊断为乳腺癌,被转介到WBBS调查可能的骨转移。在平面图像中,在颅底前部和颅顶后部的多个部位检测到放射性示踪剂摄取。单光子发射计算机断层扫描/计算机断层扫描对可能的转移灶进行解剖定位,发现检测到的放射性示踪剂积聚不属于骨转移;摄取位于脑实质和大脑镰的病变。患者病史说明她五年前被诊断为脑膜瘤,在本研究中,脑膜瘤与骨转移相似。
{"title":"Meningioma Mimicking Bone Metastasis in Breast Cancer.","authors":"Oğuzhan Şahin,&nbsp;Gündüzalp Buğrahan Babacan,&nbsp;Tamer Özülker","doi":"10.4274/mirt.galenos.2022.31032","DOIUrl":"https://doi.org/10.4274/mirt.galenos.2022.31032","url":null,"abstract":"<p><p>Meningiomas constitute 37% of primary central nervous system tumors and are more common in women. Also may occur with other primary malignancies, which can cause confusion with the metastasis in whole body bone scan (WBBS) imaging. A 58-year-old woman diagnosed with breast cancer was referred to the WBBS for the investigation of possible bone metastases. In the planar images, radiotracer uptake at multiple sites was detected on the anterior side of the skull base and the posterior side of the vertex of the cranium. Single photon emission computed tomography/computed tomography was performed for anatomical localization of possible metastatic lesions, and it revealed that detected accumulations of radiotracer did not belong to the bone metastases; uptakes were located at the cerebral parenchyma and the lesions in the falx cerebri. Patient history explained that she had been diagnosed with meningioma five years ago, which mimicked bone metastases in this study.</p>","PeriodicalId":44681,"journal":{"name":"Molecular Imaging and Radionuclide Therapy","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2023-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/60/9b/MIRT-32-165.PMC10284175.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9706695","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical Utility of CT-based Attenuation-correction in Myocardial Perfusion SPECT Imaging. 基于ct的心肌灌注SPECT成像衰减校正的临床应用。
IF 0.9 Q3 Medicine Pub Date : 2023-06-20 DOI: 10.4274/mirt.galenos.2022.68094
Filiz Hatipoğlu, Neslihan Çetin

Objectives: We aimed to investigate and compare the role of computed tomography (CT)-based attenuation-corrected images (AC) with non-attenuation-corrected images (NAC) obtained by single-photon emission computed tomography/computed tomography (SPECT/CT) myocardial perfusion imaging (MPI).

Methods: The data of 124 patients who were applied one-day stress-rest Tc-99m sestamibi SPECT/CT MPI and who had coronary angiography (CAG) results within ±3 months were retrospectively reviewed. AC and NAC images were visually evaluated by two nuclear medicine specialists in a consensus. CAG results were used as the reference standard.

Results: Specificity, sensitivity, and accuracy were calculated as 66%, 61%, 71%, 79% and 69%, 70% for AC and NAC imaging in the whole group, respectively. There was no statistically significant difference between AC and NAC images for specificity, sensitivity, and accuracy in the male and female subgroups. In the diagnosis of right coronary artery (RCA) disease, CT AC significantly increased the specificity from 87% to 96%. However, in the left anterior descending artery (LAD) region, the specificity was significantly reduced from 95% to 77%.

Conclusion: CT-based AC did not significantly contribute to diagnostic performance for increased specificity for the RCA and reduced specificity in the LAD region. Therefore, AC images should always be evaluated side by side with NAC images to benefit from the different advantages of both techniques.

目的:研究并比较基于计算机断层扫描(CT)的衰减校正图像(AC)与通过单光子发射计算机断层扫描/计算机断层扫描(SPECT/CT)心肌灌注成像(MPI)获得的非衰减校正图像(NAC)的作用。方法:回顾性分析124例应用1天压力休息Tc-99m sestamibi SPECT/CT MPI并在±3个月内进行冠状动脉造影(CAG)结果的患者的资料。AC和NAC图像由两名核医学专家在共识下进行视觉评估。CAG结果作为参考标准。结果:全组AC和NAC成像的特异性、敏感性和准确性分别为66%、61%、71%、79%和69%、70%。在男性和女性亚组中,AC和NAC图像的特异性、敏感性和准确性没有统计学差异。在右冠状动脉(RCA)疾病的诊断中,CT AC的特异性从87%显著提高到96%。然而,在左前降支(LAD)区域,特异性从95%显著降低到77%。结论:基于ct的AC对RCA的特异性增加,对LAD的特异性降低,对诊断性能没有显著贡献。因此,应始终将AC图像与NAC图像并排评估,以从两种技术的不同优势中获益。
{"title":"Clinical Utility of CT-based Attenuation-correction in Myocardial Perfusion SPECT Imaging.","authors":"Filiz Hatipoğlu,&nbsp;Neslihan Çetin","doi":"10.4274/mirt.galenos.2022.68094","DOIUrl":"https://doi.org/10.4274/mirt.galenos.2022.68094","url":null,"abstract":"<p><strong>Objectives: </strong>We aimed to investigate and compare the role of computed tomography (CT)-based attenuation-corrected images (AC) with non-attenuation-corrected images (NAC) obtained by single-photon emission computed tomography/computed tomography (SPECT/CT) myocardial perfusion imaging (MPI).</p><p><strong>Methods: </strong>The data of 124 patients who were applied one-day stress-rest Tc-99m sestamibi SPECT/CT MPI and who had coronary angiography (CAG) results within ±3 months were retrospectively reviewed. AC and NAC images were visually evaluated by two nuclear medicine specialists in a consensus. CAG results were used as the reference standard.</p><p><strong>Results: </strong>Specificity, sensitivity, and accuracy were calculated as 66%, 61%, 71%, 79% and 69%, 70% for AC and NAC imaging in the whole group, respectively. There was no statistically significant difference between AC and NAC images for specificity, sensitivity, and accuracy in the male and female subgroups. In the diagnosis of right coronary artery (RCA) disease, CT AC significantly increased the specificity from 87% to 96%. However, in the left anterior descending artery (LAD) region, the specificity was significantly reduced from 95% to 77%.</p><p><strong>Conclusion: </strong>CT-based AC did not significantly contribute to diagnostic performance for increased specificity for the RCA and reduced specificity in the LAD region. Therefore, AC images should always be evaluated side by side with NAC images to benefit from the different advantages of both techniques.</p>","PeriodicalId":44681,"journal":{"name":"Molecular Imaging and Radionuclide Therapy","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2023-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/74/8a/MIRT-32-138.PMC10284174.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9709416","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of 68Ga-PSMA PET/CT and 18F-PSMA PET/CT of a Patient with Prostate Cancer Recurrence on Urinary Bladder Wall. 1例前列腺癌膀胱壁复发患者68Ga-PSMA与18F-PSMA PET/CT的比较
IF 0.9 Q3 Medicine Pub Date : 2023-06-20 DOI: 10.4274/mirt.galenos.2023.47550
Çiğdem Soydal, Burak Demir, Gizem Sütçü, Mine Araz, Nuriye Özlem Küçük

Prostate cancer is one of the most prevalent cancers in the world. After radical prostatectomy, prostate-specific antigen (PSA) levels are usually used as a marker of recurrence for prostate cancer. In the case of increased PSA levels, 68Ga-prostate-specific membrane antigen (PSMA) or 18F-PSMA, a new alternative, can be performed for the detection of recurrent disease. We report a case of a 49-year-old male patient with increasing PSA levels who was previously operated 8 years ago. Although no obvious pathological uptake was detected in 68Ga-PSMA positron emission tomography/computed tomography (PET/CT), 18F-PSMA PET/CT revealed a lesion with pathological uptake on the urinary bladder wall.

前列腺癌是世界上最常见的癌症之一。根治性前列腺切除术后,前列腺特异性抗原(PSA)水平通常被用作前列腺癌复发的标志。在PSA水平升高的情况下,68ga -前列腺特异性膜抗原(PSMA)或18F-PSMA,一种新的替代方法,可用于检测复发性疾病。我们报告一例49岁男性患者,PSA水平升高,8年前曾做过手术。68Ga-PSMA正电子发射断层扫描/计算机断层扫描(PET/CT)未见明显病理性摄取,但18F-PSMA PET/CT显示膀胱壁上可见病理性摄取病变。
{"title":"Comparison of <sup>68</sup>Ga-PSMA PET/CT and <sup>18</sup>F-PSMA PET/CT of a Patient with Prostate Cancer Recurrence on Urinary Bladder Wall.","authors":"Çiğdem Soydal,&nbsp;Burak Demir,&nbsp;Gizem Sütçü,&nbsp;Mine Araz,&nbsp;Nuriye Özlem Küçük","doi":"10.4274/mirt.galenos.2023.47550","DOIUrl":"https://doi.org/10.4274/mirt.galenos.2023.47550","url":null,"abstract":"<p><p>Prostate cancer is one of the most prevalent cancers in the world. After radical prostatectomy, prostate-specific antigen (PSA) levels are usually used as a marker of recurrence for prostate cancer. In the case of increased PSA levels, <sup>68</sup>Ga-prostate-specific membrane antigen (PSMA) or <sup>18</sup>F-PSMA, a new alternative, can be performed for the detection of recurrent disease. We report a case of a 49-year-old male patient with increasing PSA levels who was previously operated 8 years ago. Although no obvious pathological uptake was detected in <sup>68</sup>Ga-PSMA positron emission tomography/computed tomography (PET/CT), <sup>18</sup>F-PSMA PET/CT revealed a lesion with pathological uptake on the urinary bladder wall.</p>","PeriodicalId":44681,"journal":{"name":"Molecular Imaging and Radionuclide Therapy","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2023-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/91/62/MIRT-32-150.PMC10284183.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9706692","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Brain Perfusion Changes in a Patient with Facial Trauma. 面部创伤患者的脑灌注改变。
IF 0.9 Q3 Medicine Pub Date : 2023-06-20 DOI: 10.4274/mirt.galenos.2022.90958
Chrissa Sioka, Anastasia Zikou, Petros Petrikis, Asimakis Asimakopoulos, George Alexiou, Vasileios Ragos

A 69-year-old male was admitted to our hospital because of left facial trauma with bone fractures, including the maxillary sinus, zygomatic arch, and ethmoid and sphenoid bones. Brain computed tomography was unremarkable but regional cerebral blood flow with hexamethyl-propylene-amine oxime single-photon emission computed tomography (SPECT) showed hypoperfusion of the left hemisphere, which was reversible since a repeat SPECT 4 months later was substantially improved. Brain perfusion SPECT may provide information on cerebrovascular status in some cases of facial injury.

一名69岁男性因左侧面部外伤合并骨折,包括上颌窦、颧弓、筛骨和蝶骨入院。脑部计算机断层扫描无明显异常,但六甲基丙烯胺肟单光子发射计算机断层扫描(SPECT)显示左半球脑血流不足,由于4个月后重复SPECT明显改善,这是可逆的。脑灌注SPECT可以提供一些面部损伤病例的脑血管状态信息。
{"title":"Brain Perfusion Changes in a Patient with Facial Trauma.","authors":"Chrissa Sioka,&nbsp;Anastasia Zikou,&nbsp;Petros Petrikis,&nbsp;Asimakis Asimakopoulos,&nbsp;George Alexiou,&nbsp;Vasileios Ragos","doi":"10.4274/mirt.galenos.2022.90958","DOIUrl":"https://doi.org/10.4274/mirt.galenos.2022.90958","url":null,"abstract":"<p><p>A 69-year-old male was admitted to our hospital because of left facial trauma with bone fractures, including the maxillary sinus, zygomatic arch, and ethmoid and sphenoid bones. Brain computed tomography was unremarkable but regional cerebral blood flow with hexamethyl-propylene-amine oxime single-photon emission computed tomography (SPECT) showed hypoperfusion of the left hemisphere, which was reversible since a repeat SPECT 4 months later was substantially improved. Brain perfusion SPECT may provide information on cerebrovascular status in some cases of facial injury.</p>","PeriodicalId":44681,"journal":{"name":"Molecular Imaging and Radionuclide Therapy","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2023-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/33/ff/MIRT-32-162.PMC10284177.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9706693","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hypermetabolic Axillary Lymph Nodes Associated with COVID-19 Vaccination in Breast Cancer Management. 高代谢腋窝淋巴结与COVID-19疫苗接种在乳腺癌管理中的相关性
IF 0.9 Q3 Medicine Pub Date : 2023-06-20 DOI: 10.4274/mirt.galenos.2023.82712
Cengiz Taşçı, Ahmet Dirican, Ethem Murat Sözbilen, Fatma Seher Pehlivan, Selim Serter

A 42-year-old female patient diagnosed with invasive ductal breast ca underwent 18F-fluorodeoxyglucose (FDG) positron emission tomography/ computed tomography (PET/CT) scan for staging, 1.5 cm diameter hypermetabolic lesion was observed in the lower inner quadrant of the right breast that was compatible with primary tumor [maximum standardized uptake value (SUVmax): 10.5]. No pathological 18F-FDG uptake was observed in lymph nodes whose fatty hilum was seen in the right axilla. However, in the left axilla and left deep axilla, hypermetabolic lymph nodes with a maksimum diameter of 19 mm and fatty hilum were observed (SUVmax: 8.0). In a detailed CT evaluation, these lymph nodes have thicker walls than the ones in the right axilla. The patient was questioned again and coronavirus disease-2019 (COVID-19) vaccination history (with BNT162b2, COVID-19 mRNA vaccine) was determined that was administrated to the left arm 5 days ago. Tru-cut biopsy was performed from the left aksillary lymph nodes and proved to be reactive lymphoid tissue and there was no primary or metastatic tumor in these axillary lymph node tissues. The patient was given neoadjuvant chemotherapy 4.5 months after the first 18F-FDG PET/CT, and the second was performed for the treatment response evaluation. Significant regression was determined from the findings. The patient underwent right total mastechtomy. She was being followed up with adjuvant chemotherapy and radiotherapy. In conclusion, hypermetabolic lymph nodes in the axillas should be interrogated for vaccination in patients with breast cancer. Hypermetabolic lymph nodes observed on the same side of the vaccinated arm in the 18F-FDG PET/CT scan may be related to vaccine-induced reactive lymph node enlargement. Lymph node metastasis may be excluded, especially if there are hypermetabolic lymph nodes with preserved fatty hilum in the contralateral axilla on the same side as the vaccinated arm. Active lymph nodes reactive to the vaccine become inactive after a while.

确诊为浸润性导管性乳腺的42岁女性患者行18f -氟氧葡萄糖(FDG)正电子发射断层扫描/ PET/CT扫描进行分期,右侧乳腺下内象限见直径1.5 cm的高代谢病变,与原发肿瘤相适应[最大标准化摄取值(SUVmax): 10.5]。右腋窝脂肪门淋巴结未见病理性18F-FDG摄取。左腋窝和左腋窝深部可见最大直径19 mm的高代谢淋巴结和脂肪门(SUVmax: 8.0)。在详细的CT评估中,这些淋巴结的壁比右腋窝的淋巴结壁厚。再次对患者进行问询,并确定5 d前给予左臂的冠状病毒病-2019 (COVID-19)疫苗接种史(接种BNT162b2、COVID-19 mRNA疫苗)。从左侧腋窝淋巴结进行了真切活检,证实是反应性淋巴组织,这些腋窝淋巴结组织中没有原发性或转移性肿瘤。患者在第一次18F-FDG PET/CT检查后4.5个月给予新辅助化疗,第二次进行治疗反应评估。根据研究结果确定了显著的回归。患者行右侧全乳切除术。她正在接受辅助化疗和放疗。总之,乳腺癌患者应检查腋部高代谢淋巴结,以便接种疫苗。18F-FDG PET/CT扫描在接种疫苗的同侧观察到的高代谢淋巴结可能与疫苗诱导的反应性淋巴结肿大有关。淋巴结转移可以排除,特别是如果在接种疫苗的手臂同一侧的对侧腋窝存在高代谢淋巴结并保留脂肪门。对疫苗有反应的活跃淋巴结在一段时间后变得不活跃。
{"title":"Hypermetabolic Axillary Lymph Nodes Associated with COVID-19 Vaccination in Breast Cancer Management.","authors":"Cengiz Taşçı,&nbsp;Ahmet Dirican,&nbsp;Ethem Murat Sözbilen,&nbsp;Fatma Seher Pehlivan,&nbsp;Selim Serter","doi":"10.4274/mirt.galenos.2023.82712","DOIUrl":"https://doi.org/10.4274/mirt.galenos.2023.82712","url":null,"abstract":"<p><p>A 42-year-old female patient diagnosed with invasive ductal breast ca underwent <sup>18</sup>F-fluorodeoxyglucose (FDG) positron emission tomography/ computed tomography (PET/CT) scan for staging, 1.5 cm diameter hypermetabolic lesion was observed in the lower inner quadrant of the right breast that was compatible with primary tumor [maximum standardized uptake value (SUV<sub>max</sub>): 10.5]. No pathological <sup>18</sup>F-FDG uptake was observed in lymph nodes whose fatty hilum was seen in the right axilla. However, in the left axilla and left deep axilla, hypermetabolic lymph nodes with a maksimum diameter of 19 mm and fatty hilum were observed (SUV<sub>max</sub>: 8.0). In a detailed CT evaluation, these lymph nodes have thicker walls than the ones in the right axilla. The patient was questioned again and coronavirus disease-2019 (COVID-19) vaccination history (with BNT162b2, COVID-19 mRNA vaccine) was determined that was administrated to the left arm 5 days ago. Tru-cut biopsy was performed from the left aksillary lymph nodes and proved to be reactive lymphoid tissue and there was no primary or metastatic tumor in these axillary lymph node tissues. The patient was given neoadjuvant chemotherapy 4.5 months after the first <sup>18</sup>F-FDG PET/CT, and the second was performed for the treatment response evaluation. Significant regression was determined from the findings. The patient underwent right total mastechtomy. She was being followed up with adjuvant chemotherapy and radiotherapy. In conclusion, hypermetabolic lymph nodes in the axillas should be interrogated for vaccination in patients with breast cancer. Hypermetabolic lymph nodes observed on the same side of the vaccinated arm in the <sup>18</sup>F-FDG PET/CT scan may be related to vaccine-induced reactive lymph node enlargement. Lymph node metastasis may be excluded, especially if there are hypermetabolic lymph nodes with preserved fatty hilum in the contralateral axilla on the same side as the vaccinated arm. Active lymph nodes reactive to the vaccine become inactive after a while.</p>","PeriodicalId":44681,"journal":{"name":"Molecular Imaging and Radionuclide Therapy","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2023-06-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ca/0f/MIRT-32-181.PMC10284176.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9700475","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Rare Case and Atypical Metastatic Regions, Pulmonary Giant Cell Carcinoma. 肺巨细胞癌一例罕见及非典型转移区。
IF 0.9 Q3 Medicine Pub Date : 2023-02-23 DOI: 10.4274/mirt.galenos.2022.50133
Ceyda Nur Dündar Çağlayan, Müge Nur Engin, Adil Boz

Sixty two years old man referred to our clinic due to suspicion of thymic mass. The hypermetabolic nodular lesion in the right lung upper lobe was seen in 18F-fluorodeoxyglucose (FDG)-positron emission tomography/computed tomography (PET/CT) in addition to the mass in the anterior mediastinum which was found to without malignancy. The patient underwent wedge resection and final diagnosis was pulmonary giant cell carcinoma. In follow-up 18F-FDG PET/CT multiple lesions with pathological activity were observed in the cerebrum, right postauricular region, bilateral adrenal, stomach, pancreas, pelvic soft tissue, mesenteric, left femur and bilateral lung parenchyma 6 months after. The pathology results of the right frontal, pelvic mass and the postauricular region were metastasis.

男,六十二岁,疑胸腺肿块而来。右肺上叶除前纵隔肿块外,18f -氟脱氧葡萄糖(FDG)-正电子发射断层扫描/计算机断层扫描(PET/CT)见高代谢性结节状病变,未见恶性肿瘤。患者行楔形切除,最终诊断为肺巨细胞癌。随访6个月后,18F-FDG PET/CT在大脑、右侧耳后区、双侧肾上腺、胃、胰腺、盆腔软组织、肠系膜、左股骨、双侧肺实质等部位观察到多发病变,均有病理活动。右侧额部、盆腔肿块及耳后区均有转移。
{"title":"A Rare Case and Atypical Metastatic Regions, Pulmonary Giant Cell Carcinoma.","authors":"Ceyda Nur Dündar Çağlayan,&nbsp;Müge Nur Engin,&nbsp;Adil Boz","doi":"10.4274/mirt.galenos.2022.50133","DOIUrl":"https://doi.org/10.4274/mirt.galenos.2022.50133","url":null,"abstract":"<p><p>Sixty two years old man referred to our clinic due to suspicion of thymic mass. The hypermetabolic nodular lesion in the right lung upper lobe was seen in <sup>18</sup>F-fluorodeoxyglucose (FDG)-positron emission tomography/computed tomography (PET/CT) in addition to the mass in the anterior mediastinum which was found to without malignancy. The patient underwent wedge resection and final diagnosis was pulmonary giant cell carcinoma. In follow-up <sup>18</sup>F-FDG PET/CT multiple lesions with pathological activity were observed in the cerebrum, right postauricular region, bilateral adrenal, stomach, pancreas, pelvic soft tissue, mesenteric, left femur and bilateral lung parenchyma 6 months after. The pathology results of the right frontal, pelvic mass and the postauricular region were metastasis.</p>","PeriodicalId":44681,"journal":{"name":"Molecular Imaging and Radionuclide Therapy","volume":null,"pages":null},"PeriodicalIF":0.9,"publicationDate":"2023-02-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/26/ae/MIRT-32-74.PMC9950673.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10778318","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Molecular Imaging and Radionuclide Therapy
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1